[Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].

@article{Furuse1994PercutaneousIT,
  title={[Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].},
  author={F Furuse and Yoichi Nakanishi and H Kotoh and Hideki Inoue and Jun Yatsunami and Tetsuo Ikeda and Nobuyuki Hara},
  journal={Nihon Kyobu Shikkan Gakkai zasshi},
  year={1994},
  volume={32 6},
  pages={538-43}
}
We have performed percutaneous intracavitary treatment with anti-fungal reagents in 8 patients with pulmonary aspergilloma (6 males and 2 female) over the past decade. Ages ranged from 43 to 84 years old. All of the patients had underlying lung diseases, seven having old pulmonary tuberculosis and one pneumoconiosis. Five patients had a history of… CONTINUE READING